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The role of the complement system in the production of mediators of the acute 
inflammatory response is now well established.  Two general classes of media- 
tors have been identified: the chemotactic factors for neutrophils (reviewed in 
1, 2) and the anaphylatoxins (reviewed in 3). Considering both categories, it is 
possible in an inflammatory reaction, where complement plays a role, to account 
for the two cardinal features of the acute inflammatory response, i.e., accumu- 
lation of neutrophils and increased vascular permeability. The usual view re- 
garding the generation of these complement-derived mediators is that they re- 
sult from sequential interactions of the complement system. In recent years it 
has become apparent that certain enzymes can act directly on individual com- 
plement components, and in so doing generate mediators in a manner that by- 
passes all other components of the complement system (2,  4). 
The work to be presented here relates to the "bypass" concept and involves 
a  tissue protease found in myocardium (as well as many other normal tissues 
[5]). This enzyme cleaves the third component of complement (C3) into chemo- 
tactically active fragments. In the course of "nonspecitic" tissue injury, namely 
anoxia induced by ligation of a coronary artery in the rat, C3-cleavage products 
with  chemotactic  activity have been found  in  the  damaged  heart  tissue.  It 
seems probable that  these  products  reflect  the  release  of  the  tissue  protease 
followed by its action on the substrata C3. The finding of C3 chemotactic prod- 
ucts, together with the results from certain manipulations of the animal model, 
suggest that the acute inflammatory response to this type of nonspecific tissue 
injury is a complement-dependent reaction due to the release of the C3-cleaving 
enzyme, the production of C3 fragments, and the accumulation of neutrophils. 
These data provide further evidence for a central role of the complement system 
in the generation of phlogistic mediators. 
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Materials and Methods 1 
Surgical Procedure.--Under  general anesthesia (Fluothane), and with externally assisted 
breathing, 250 g female outbred Wistar rats were subjected to left lateral thoracotomy in the 
eighth intercostal space. After retraction of ribs the left coronary artery was tied off close to 
its origin with a 4-0 silk ligature (6). The chest was then closed in two layers with interrupted 
silk sutures. Monitoring of the myocardial infarcts was accomplished by electrocardiographic 
tracings before  and  after  arterial ligation to  insure  that the electrical changes  associated 
with infarction were produced. Rats were  sacrificed at  appropriate  intervals after coronary 
artery ]igation by general anesthesia (see  above) and exsanguinated from the inferior vena 
cava.  The infarcted area of  myocardium was characterized by the usual gross morphologic 
changes of paleness and  peripheral hemorrhage. Fresh myocardial  tissue was  obtained  for 
extraction of chemotactic activity. For routine light microscopy tissue sections were fixed  in 
formalin buffered at neutral pH. 
Tissue Extraction Procedures.--Blocks  of tissue 200-400 mg were finely minced, and then, 
after the addition of 2.0 ml of phosphate-buffered saline (pH 7.3),  homogenized in a Virtis 45 
instrument (The Virtis Co., Inc., Gardiner, N. Y.) at 37,000  rpm for a total of 9 rain at 5°C. 
A  supernate was separated from the sedimentable fraction by centrifugation at 80,000 g for 
20 rain. 
Gd  Filtration.--Soluble  tissue  extracts  were  fractionated  by  filtration through  Sepha- 
dex G-75  (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) using a phosphate buffer (pH 
7.3,  r  -- 0.05). Standard protein markers including bovine serum albumin (BSA), cytochrome 
c, and glucagon were employed. These procedures are described in detail elsewhere (5). 
Ultracentrifugation.--An  International  B60  ultracentrifuge  (International  Equipment 
Company, Needham Heights, Mass.) was employed at 55,000  rpm for 14 hr at 4°C, using an 
SB405 rotor. The sucrose gradient consisted of 7.5-35% sucrose in the phosphate buffer (pH 
7.3)  listed above. 
Assays for Chemotactic A ctivity.--Using  neutrophilic granulocytes obtained from a glycogen- 
induced  rabbit  peritoneal  exudate,  chemotactic  activity  was  assayed  with  the  modified 
Boyden chambers which contain micropore filters of pore size 0.65/z  (7, 8). Chemotactic ac- 
tivity of a particular sample is that sum of counts of cells which have migrated in five fields 
in the filter (at high power magnification) in response to a chemotactic agent. 
Antibody Preparations.--Antibody  to rat C3 and antibody to human C5, which cross-reacts 
with rat C5 (9), were employed. These preparations are described in an earlier report (5). 
Sources of C3.--Human  C3 was purified from  serum  by the procedures  of Nilsson and 
Mfiller-Eberhard (9). These involve isoelectric precipitation, ion-exchange chromatography in 
diethylaminoethyl  (DEAE)-cellulose,  and  chromatographic  elution  from  hydroxyapatite. 
The radiolabeled C3 was a gift from Doctors Irwin H. Lepow and Sheldon Taubman (Farming- 
ton, Conn.). 
C3 Inactivator.--Lyophilized  venom from Naja naja  (obtained from Ross Allen Reptile 
Institute, Silver Springs, Fla.) was ffactlonated by ion-exchange chromatography on DEAE- 
cellulose (Mann Laboratories, New York) according to the directions of Cochrane (10). The 
appropriate fractions containing C3 inactlvator were devoid of lethal cobra toxin (as assayed 
by intraperitoneal injection into mice). Rats were injected with  150-250 units of C3 inac- 
tivator (10) by multiple intraperitoneal injections over an 8 hr period. This treatment ablated 
detectable serum levels of C3 as measured by immunochemical techniques with double dif- 
fusion in gel. 
1 The Principles of Laboratory Animal Care as promulgated  by the National Society for 
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RESULTS 
Preparation of Leukotactic Factor-Producing Substance from Normal Rat Heart. 
--In the previous study tissue minces were used as a  source for material,  pre- 
sumably an  enzyme, that  cleaves  C3  into leukotactic fragments  (5).  An im- 
proved  extraction  procedure  involving  tissue  homogenization  as  described 
above was utilized.  Tissue minces obtained by the previous method (5)  were 
interacted with rat serum or purified human C3 to produce chemotactic activity 
(Table I). When the tissue homogenate of normal rat heart was used no chemo- 
tactic factor-generating activity was found in  the sedimentable fraction,  but 
high activity was present in the supernatant fraction (Table I).  These results 
TABLE I 
Chemotactic Factor Generating Activity in Heart Tissue Mince, and Homogenate 
Sample tested  Chemotactic 
activity 
Tissue mince 
5 mg +  ....  10 
5 mg +  100 ~1 rat serum  210 
5 mg+ 100 ug C3  160 
100 #1 rat serum  0 
100 ~1 C3  0 
Virtis homogenate 
5 mg sediment +  ....  0 
5 mg sediment +  100 ~1 rat serum  10 
5 mg sediment +  100 ~g C3 (human)  0 
100 ~l supernate +  ....  0 
100/~1 supernate +  100 ul rat serum  170 
100 ~1 supernate +  100 ug C3  60 
indicate that the extraction procedure permits solubilization of the C3-cleaving 
factor (previously termed tissue protease [5]) and suggest that the enzyme may 
be associated with soluble cytoplasmic components of heart cells. 
Characterization  of the C3-Cleaving  Factor and its C3-Cleavage Products.--The 
supernate of the tissue homogenate described above was eluted from Sephadex 
G-100 and from the resulting fractions 50 #1 were incubated  with 50 #g of C3 
for 30 rain at 37°C. The  mixture was then assayed for chemotactic activity. 
While some chemotactic factor-generating activity eluted in the  void volume, 
most was found in fractions eluting immediately after the BSA marker (Fig. 1). 
These results  suggest that  the putative  C3-cleaving enzyme has a  molecular 
weight slightly less than that of BSA. 
A  supernatant sample of 150/zl from the heart homogenate was incubated 
with 150 #g of C3 in a volume of 300/A at 37°C for 30 rain, followed by elution 
of  the  mixture  from  Sephadex  G-75.  The  resulting  fractions  assessed  for 888  I~HLOGISTIC  ROLE  OF  C3  LEUKOTACTIC  FRAGMENTS 
ehemotactic activity showed a heterogeneity in distribution (Fig. 2)  with some 
activity in the void volume, but the bulk of activity appeared in areas beyond 
the cytochrome c marker. The distribution of this activity in the retarded zones 
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Fro.  1. Localization of chemotactic  factor-generating activity in fractions of rat heart 
homogenate eluted from Sephadex G-100. Activity appears near the void (Vo) volume as well 
as just beyond the albumin (BSA) marker. 
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FIG. 2.  Elution from  Sephadex  G-75 of C3 treated with an extract of normal rat myo- 
cardium. Vertical bars represent chemotactic activity  for neutrophils. 
of the chromatogram is in contrast to the larger C3 fragments produced when 
a mince of heart tissue was used as the enzyme source (5). 
Direct Demonslration of Cleavage of C3 by Factor in Heart Homogenate.--lO 
#1 of radiolabeled C3 (approximately 2/zg) together with 100 #1 (50 #g) of non- 
labeled C3 were incubated with 50 ~1 of supernate from the heart homogenate 
for 30 min in a  total volume of 300 #1 containing 0.025 M phosphate buffer, pH JEFFREY  H.  HILL  AND  PETER  A.  WARD  889 
7.3. Mter this the material was placed in a sucrose density gradient. A cleavage 
product from C3 was found in the slowly sedimenting region of the gradient 
(Fig.  3,  upper frame, fractions 14-16)  coinciding with a  peak of chemotactic 
activity (lower frame). Additional peaks of chelnotactic activity were also found 
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FIO. 3.  Cleavage of human C3 by treatment with extract from normal rat myocardium. 
The cleavage product, as measured by radioactivity (upper frame, broken line (X  X), 
fraction 14-16), coincides  with a peak of chemotactic  activity (lower  frame). Cytoch. c stands 
for cytochrome  c. 
in fraction 17, as well as in fractions 3 and 5. The latter may represent an altered 
but, as yet, uncleaved C3 molecule. The untreated C3 preparation failed to show 
a peak of radioactivity in the upper region of the gradient (Fig. 3, upper frame). 
Time Course in Appearance  of Chemotactic Activity in Infarcted Myocardium. 
--Extracts from infarcted heart tissue were obtained at various intervals after 
coronary artery ligation (Fig. 4). Each point represents the mean of chemotactic 
activity in 100 #1 extracts from each of four different hearts. The standard devia- 890  PHLOGISTIC  ROLE  OF  c3  LEUKOTACTIC  FRAGMENTS 
tion is shown by the vertical bars. Minimal activity was found in tissues 2 hr 
after ligation  of  the  coronary artery,  whereas maximal activity appeared  at 
3-4 hr. Thereafter, activity diminished over the next 2 hr and was barely de- 
tectable after the 6th hr. Several extracts were  examined for susceptibility  of 
chemotactic activity of inhibition  by antibody to rat  C3  (anti-C3).  50/~1  of 
antibody was added to 100/zl of extract, incubated at room temperature for 15 
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FIG. 4. Time course in appearance of extractable chemotactic activity  in infarcted rat 
myocardium, as a function of hours after ligation of coronary artery. Most of the activity can 
be suppressed with antibody to C3. 
min, then assayed for chemotactic activity. It is apparent that, with the excep- 
tion of the 5 hr sample, all activity could be suppressed  with anti-C3  (Fig. 4, 
dotted line). 
Behavior in Gel Filtration  of Chemotactic Activity Extractable from Infarcted 
Myocardium.--An extract of infarcted myocardium obtained 3 hr after ligation 
of the coronary artery was eluted from Sephadex G-75.  Considerable hetero- 
geneity of activity was found. Two areas of chemotactic activity were found at 
and beyond the position of the void volume; a third area of activity was present 
in fractions eluting immediately after the glucagon marker (Fig. 5). When the 
extract of myocardium obtained 5.5  hr after coronary artery ligation was ex- JEFFREY  H.  HILL  AND  PETER  A.  WARD  891 
amined by gel filtration, the pattern of chemotactic activity was somewhat dif- 
ferent. No significant activity was found in the void volume, low grade activity 
appeared near the cytochrome c marker, but most was found just before or just 
after the glueagon marker (Fig. 6).  These results suggest that the later (5.5 hr) 
infarcts  contain  smaller  chemotactically  active  molecules  than  infarcts  ob- 
tained at the 3 hr interval. 
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FIG.  5.  Elation from Sephadex 0-75 of chemotactic activity in 3-hr old infarcted rat myo- 
cardium. The activity is heterogenous. 
Also shown in Fig. 6 is the susceptibility of chemotactic activity in the various 
fractions to inhibition by the addition of anti-C3.  This experiment was per- 
formed by adding 50/~1 of anti-C3 to 100/~1 samples from the Sephadex column. 
Little inhibition of chemotactic activity in fractions 11, 13, and 14 was found, 
whereas in fractions 20, 21, 25, 26, and 27 half to two-thirds of the activity was 
suppressed by this treatment. These data provide the most direct evidence that 
chemotactic activity in extracts from infarcted myocardial tissue is attributable 
to cleavage products of C3. 892  PHLOGISTIC  ROLE  OF  C3  LEUKOTACTIC  ~FRAGMENTS 
Ultracentrifugal  Behavior  of Chemotaclic  Activity  in  an  Extract  of Infarcted 
Myocardium.--The  same sample  analyzed  in  Fig.  6 was subject  to ultracen- 
trifugal analysis (Fig. 7). As anticipated,  chemotactic activity appeared in the 
upper portion of the gradient,  forming a heterogeneous pattern,  with activity 
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FIG.  6.  Elution from Sephadex G-75 of an extract of a  5.5-hr old myocardial infarct. The 
activity is later eluting, compared with Fig. 5, and much of the activity is C3-related. 
TABLE  II 
C3 Dependence of Leukotactic Activity in Myocardial Infarcts of Rats 
Chemotactic 
Treatment  Serum  C'H~0  Serum  C3"  activity in 
tissue extract ~. 
(units/ml) 
None 
Rat  1 
Rat 2 
Rat 3 
C3 inactivator 
Rat 4 
Rat 5 
Rat 6 
Rat 7 
Rat 8 
25  Present  130 
> 18  Present  220 
26  Present  250 
<6  Absent  10 
< 6  Absent  60 
< 6  Absent  0 
<6  Absent  0 
< 6  Absent  0 
* As determined by immunochemical assay (see Fig. 8). 
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just above and just below the cytochrome c marker. This provided additional 
evidence for C3 products of low molecular weight. 
The Effect  of C3 Inactivation  on Appearance  of Chemotacfic  Acfivily  in  Ex- 
tracts of Myocardial Infarcts in Rats.--Rats  were treated 1.5  days before coro- 
nary artery ligation with C3 inactivator (purified from cobra venom) in amounts 
sufficient to completely abolish serum C3, as measured by Ouchterlony analysis. 
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FIG. 7.  Ultracentrifugal separation in a sucrose density gradient of chemotactic activity in 
an extract of a 5.5-hr old infarct, the same as in Fig. 6. As expected, the chemotactic activity 
sediments slowly. 
Serum from rats Nos. 1 and 3, which were not treated with the C3 inactivator, 
possessed normal levels of hemolytic activity for complement 5 hr after coronary 
artery ligafion  (Table II).  As expected,  immunodiffusion showed the  typical 
precipitin bands for C3 (Fig. 8). Tissue extracts from the infarcted myocardium 
of these  control  rats revealed abundant  chemotactic activity  (Table II).  On 
the other hand, five rats treated with C3 inactivator had no serum complement 
as measured by total  hemolytic complement activity  (Table II).  Their  sera 
failed to show C3 by immunodiffusion (Fig. 8). With the exception of a single 
rat (Table II, No. 5),  none had extractable chemotactic activity in the heart 894  PHLOGISTIC  ROLE  OF  C3  LEUKOTACTIC  FRAGMENTS 
tissue.  The data  are in accord with  the findings presented  above and support 
the  conclusion  that  chemotactically  active  C3  fragments  appear  in  infarcted 
myocardium. 
ttistologic Features of Aculely Infarcted Rat Hearls.--During  the first 24-48 
hr after ligation of the coronary artery,  the myocardium underwent  the char- 
acteristic changes of coagulation necrosis, hemorrhage, and an intense accumu- 
FIG. 8.  Analysis by double diffusion in gel of rat C3. Sera are in peripheral wells, anti-C3 
in center well. Wells at 12 and 4 o'clock contain control sera from rats whose coronary arteries 
were ligated 4 hr earlier. The other  four wells contain  sera from rats with  ligated  arteries 
(4-7, Table II) pretreated  with C3 inactivator.  No C3 activity is present. 
lation  of neutrophils.  In Fig.  9  the typical extravascular  accumulation of red 
cells and neutrophils is seen adjacent to the infarcted muscle. In contrast, those 
rats depleted of C3 showed the changes of coagulation necrosis accompanied by 
hemorrhage but few if any neutrophils accumulated in the infarcted tissue (Fig. 
10). Rats treated with the C3 inactivator did not develop a leukopenia or neu- 
tropenia,  ruling out the depletion of neutrophils from the circulation as an ex- 
planation  for the failure  of these  cells  to  accumulate  in  the  infarcted  tissue. 
These findings are in concert with the hypothesis that neutrophils  accumulate 
in infarcted heart  tissue in response  to the local production of C3 leukotactic 
products after release of the C3-cleaving enzyme from damaged tissue. JEFFREY H. HILL AND  PETER  A. WARD  895 
FIG.  9.  Photomicrograph from control rat heart 24 hr after ligation of coronary artery. 
The infarcted myocardium contains numerous red cells as well as neutrophilic granulocytes. 
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FIG.  10.  Photomicrograph of infarcted rat myocardium at 48 hr after ligation of coronary 
artery. This rat was C3-depleted.  Myocardium shows typical changes of coagulation necrosis 
and some hemorrhage, but even 2 days after the infarct no neutrophils are seen. Hematoxylin 
and eosin;  X  395. JEFFREY  H.  HILL  AND  PETER  A.  WARD  897 
DISCUSSION 
The necessity of C3 for the accumulation of neutrophils in response to acutely 
infarcted rat myocardium is a logical sequel to the recent findings of a factor 
(presumably an  enzyme) in most normal  tissues,  including myocardium (5). 
This enzyme has the capacity to cleave C3 into leukotactic fragments, and it 
seemed reasonable to consider that in nonspecific tissue injury, such as a myo- 
cardial infarct, this enzyme would be released from its residence in tissue (the 
localization of which,  whether  parenchyma or  stroma,  is  not  known),  after 
which contact with the substrate would lead to cleavage of C3 and generation 
of chemotactic activity. The logical outcome would  be  the  accumulation  of 
neutrophils. 
This problem was directly approached by isolating and identifying C3 leuko- 
tactic products in infarcted tissue. By manipulating the model, depletion of C3 
in rats led to the failure to detect chemotactic activity in extracts of infarcted 
tissue. Coincidentally, ablation of C3 in the serum by the C3 inactivator pre- 
cluded the appearance of neutrophils in the infarcted tissue. 
This model seems to be a prototype in which, through a bypass of the con- 
ventional complement sequence (i.e. sequential interaction of complement com- 
ponents is not operational), an enzyme can act directly on one intact comple- 
ment  (C3)  to generate factors with phlogistic potential.  This emphasizes the 
potential role of complement in the generation, by nonimmunologic means, of 
mediators of the acute inflammatory response. The findings of other enzymes 
such as trypsin, plasmin, and thrombin (4), each of which can cleave C3 with 
the liberation of C3a possessing chemotactic as well as anaphylatoxic properties, 
simply emphasizes the various ways in which C3 can be cleaved into biologically 
active fragments. 
In terms of the bypassing of the conventional interaction of the complement 
sequence, a very similar story has now begun to unfold for C5. C5a can be pro- 
duced directly by the action of trypsin (11) and by a neutral protease extracta- 
ble from lysosomal granules of the neutrophil (11). Even C1 can be activated 
by trypsin or plasmin (see review in reference 12), but in this case its activation 
results in the interaction with its natural substrates of the complement system, 
C4 and C2. It is not completely clear if the activation of C1 by these enzymes is 
productive of biologically active fragments from C3 and C5, although such prod- 
ucts would be anticipated. 
Relating the work in this case to previous studies requires some comments. 
To begin with,  the C3-cleavage products extractable from infarcted rat myo- 
cardium are heterogeneous, bu( this is not surprising in view of the fact that 
incubation of tissue minces gives at least  two C3-cleavage products with  esti- 
mated molecular weights of 14,000 and 30,000 (5). In the present study, how- 
ever,  C3  fragments of considerably lower molecular weight have been found 
when the enzyme preparation (obtained in soluble form from the heart homog- 898  PHLOGISTIC  ROLE  OF  C3  LEUKOTACTIC  FRAGMENTS 
enate) is incubated with C3 or when C3-cleavage products from infarcted tis- 
sues are extracted and eluted from Sephadex. Such differences can be accounted 
for by a more active enzyme preparation. This is not surprising, since contact 
of C3  with  the enzyme present  in  the  tissue mince would probably be very 
limited (5). Thus, it appears that the action of the enzyme prepared from the 
tissue  homogenate, rather  than  from the  tissue mince,  more closely reflects 
what happens locally to C3 in the course of a myocardial infarct. 
It is of interest that not all the extractable chemotactic activity in infarcted 
myocardium is related to C3,  at least at 5 hr after coronary ligation (Fig. 4). 
Other  candidates for  chemotactic mediators  include  C5a  (13)  and  collagen- 
breakdown products (14). The former could be due to the release of the CS- 
cleaving  enzyme from lysosomal granules  of neutrophils  (13)  that  have re- 
sponded to the initial chemotactic stimulus in the infarcted myocardium. For 
this to occur, however, it would be necessary to postulate either the damage or 
destruction  of neutrophils responding  to  the  infarcted tissue,  or  the specific 
release of the lysosomal product through a phagocytic mechanism. The possi- 
ble role of collagen-breakdown products as another chemotactic stimulus also 
has  to be  considered,  although  the relative lack  of collagen  (substrate)  and 
fibroblasts (source of collagenase) in the heart reduce the likelihood of this ex- 
planation. The data in Fig. 4 certainly suggest that C3 products are the earliest 
and  the  predominant  chemotactic factors.  In  the  absence of C3  little  other 
chemotactic activity appears  (Table II). 
Finally, these findings must be put into the perspective of clinical medicine. 
In the first place, although we know that human myocardium (as well as many 
other tissues) contains a C3-cleaving enzyme (5), there are no data with human 
material to indicate if, in fact, C3-cleavage products are produced in infarcted 
myocardium. In the second place,  the experimental studies in the rat do not 
allow for any definite statement regarding the outcome of the infarct in  the 
absence of neutrophils. The exclusion of these cells in the inflammatory reaction 
has not been associated with any obvious defect in the formation of granulation 
tissue in the infarcted heart3  C3-depleted rats seem to lay down a dense fibrous 
scar in the infarcted tissue in the absence of neutrophils and C3, just as did the 
control rats. There are no obvious effects of the  C3 depletion,  either in the in- 
tensity of the myocardial damage, or in the healing of the infarcted heart, but 
both parameters are very difficult to measure objectively. 
SUMMARY 
An improved method is described for extraction from rat myocardium of an 
enzyme that cleaves the third component of complement (C3) into leukotactic 
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fragments. Direct cleavage of C3 has been shown by the use of a radiolabeled 
preparation of human C3. The enzyme elutes slightly beyond (retarded  to) an 
albumin marker in gel filtration. 
After surgical ligation of a  coronary artery,  leukotactic activity can be ex- 
tracted from infarcted rat myocardium. Described  in terms  of its time of ap- 
pearance  in  infarcted  tissue,  the  leukotactie  activity  has  been  identified  as 
cleavage products of rat C3. The C3 fragments are of low molecular weigh  t and 
heterogenous in size. 
Rats, if treated with the C3 inactivator (isolated from cobra venom) so as to 
ablate  serum  C3,  fail  to  develop  leukotactic  activity  in  the  infarcted  myo- 
cardium. In turn, few if any of the usual intense accumulations of neutrophils 
in response to infected myocardium are seen during the first 48 hr after coronary 
artery ligation. 
These studies suggest a nonimmunologic role for C3 in the mediation of the 
acute inflammatory response in nonspecific tissue injury. 
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